Please ensure Javascript is enabled for purposes of website accessibility

Dow Falls 350 Points as Coronavirus Fears Grow

By Mark Prvulovic - Jan 27, 2020 at 3:23PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Markets are starting the week off on a worried note, with major exchanges around the world reporting major losses.

U.S. stocks saw significant losses on Monday as news of the deadly coronavirus worries investors. The Dow Jones Industrial Average is down 350 points or 1.2% this morning, while the S&P 500 is also down 1.2%. The tech-oriented Nasdaq shed 140 points, down 1.5%.

According to Chinese officials, the death toll in China has grown to 81. The National Health Commission stated that over 2,700 people have been diagnosed with the condition, mainly in the Hubei province of China which is now in lockdown. The number of U.S. cases has gone up as well, from just one individual diagnosed with the coronavirus before the weekend to now five people.

Red recession arrow pointing down on a stock market screen.

Image source: Getty Images.

It's been over three months since the S&P 500 moved up or down over 1% in a single trading day. Stocks have steadily gone up since October when the Trump Administration confirmed that it was close to signing a phase-one trade deal with China. However, worries of a global outbreak are pushing down global equities markets and are threatening to give back much of the gains made over the past couple of months.

The big picture

While the outbreak is still contained in China for the most part, U.S. companies that have significant operations in the country have been hit hard. Small-pharmaceutical stocks with antiviral programs, however, have been the biggest winners so far since news of the coronavirus first came out.

One of them is Inovio Pharmaceuticals (INO 0.97%), which saw its stock shoot up by over 30% on Monday, extending already impressive gains. Novavax (NVAX 4.35%) and Moderna (MRNA 3.49%) are two other healthcare companies that have caught attention since the outbreak started, with shares rising by 9.5% and 5.7% respectively today.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Novavax, Inc. Stock Quote
Novavax, Inc.
NVAX
$66.30 (4.35%) $2.76
Inovio Pharmaceuticals, Inc. Stock Quote
Inovio Pharmaceuticals, Inc.
INO
$2.08 (0.97%) $0.02
Moderna, Inc. Stock Quote
Moderna, Inc.
MRNA
$165.13 (3.49%) $5.58

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
322%
 
S&P 500 Returns
113%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/07/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.